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(MI+ADSCs: 43.85.6%; MI+PBS: 37.23.0%). ShPHD2-ADSCs exerted signiﬁ-
cantly more protection (infarct size: 22.63.0%; LVEF: 67.36.8%; P<0.05 vs.
MI+ADSCs). PHD2 silencing induced greater ADSC survival (survival rate at 7 days
post-transplantation: shPHD2-ADSCs: 14.74.2% vs. ADSCs: 3.40.8%, P<0.05),
which was abolished by HIF-1alpha silencing. None of the ADSCs gave rise to
cardiomyocytes, and ADSC-induced cardioprotection was mainly induced by para-
crine function. Conditioned medium from shPHD2-ADSCs decreased cardiomyocyte
apoptosis. Insulin-like growth factor-1 (IGF-1) levels were 3.8 times higher in the
conditioned medium of shPHD2-ADSCs than ADSCs, and depletion of IGF-1
attenuated the cardioprotective effects of shPHD2-ADSC-conditioned medium.
NF-kappaB activation was induced by shPHD2 to stimulate IGF-1 secretion via
binding to the IGF-1 gene promoter. A combination of HIF-1alpha silencing and IGF-
1 neutralization blocked the beneﬁcial effects of shPHD2-ADSCs for MI. Similar
ﬁndings were observed with BM-MSCs.
Conclusions: PHD2 silencing promotes stem cell survival in infarcted hearts and
enhances their paracrine function to protect cardiomyocytes. Its prosurvival effect on
stem cells is HIF-1alpha dependent, while it enhances stem cell paracrine function
through NF-kappaB-mediated IGF-1 upregulation. PHD2 silencing in stem cells may
be a novel strategy for enhancing the effectiveness of stem cell therapy after MI.
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IRAK4 Deﬁciency Promotes Cardiac Remodeling
Yuan Yuan1,2, Qizhu Tang1,2
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Research Institute of Wuhan University
Objectives: To investigate the role of Interluekin1 receptor-associated kinase-4
(IRAK4), which plays an essential role in the innate immune system, in cardiac
remodeling induced by pressure overload and elucidate the underlying mechanisms.
Methods: In vivo studies were performed using IRAK4 heterozygous knockout
(IRAK4+/-) mice and wild type (IRAK4+/+) mice. Models of cardiac remodeling were
induced by aortic banding (AB). Cardiac remodeling was evaluated by Echocardi-
ography, catheter-based measurements of hemodynamic parameters and histological
analysis. In vitro studies were performed using H9c2 cardiomyoblasts with over-
expression of IRAK4 or not. Models of cardiomyoblast hypertrophy were induced by
Angiotension II (AngII) treatment. Cardiomyoblast hypertrophy was evaluated by
immunoﬂuorescent staining of a-actin. mRNA and protein expression were detected
by real-time PCR and Western Blot analysis.
Results: IRAK4 was upregulated in pressure overload induced mice heart. IRAK4+/-
mice exhibited exacerbated cardiac hypertrophy, dysfunction and ﬁbrosis after 4
weeks of aortic banding (AB) compared with that in wild-type mice. Furthermore,
enhanced activation of the MEK-ERK1/2, p38 and NFkB pathways was found in
IRAK4+/- mice compared to WT mice.
While IRAK4 overexpression signiﬁcantly attenuated cardiomyoblasts hypertrophy
induced by AngII accompaning with decreased expression of hypertrophic markers,
including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and
decreased activation of the MEK-ERK1/2, p38 and NFkB pathways.
Conclusions: IRAK4 may play a crucial role in the development of cardiac remod-
eling via negative regulation of mutiple signaling pathways.
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S1P/S1PR2 mediated vascular endothelial cells dysfunction through upregulating
miRNA-31 expression in human coronary artery endothelial cells exposed to
high glucose
Liu Weihua, Liu Shiming
Guangzhou Institute of Cardiovascular Disease, the Second Afﬁliated Hospital of
Guangzhou Medical University
Objectives: Diabetes is high risk factor for cardiovascular disease including athero-
sclerosis and coronary heart disease. Vascular endothelial dysfunction is the initiating
factor and early manifestation of diabetic vascular disease. Our preliminary study has
shown that sphingosine-1-phosphate (S1P) was signiﬁcantly increased in serum of
diabetic rats. sphingosine-1-phosphate receptor type 2 (S1PR2) was the overwhelming
S1P receptor expressing in human coronary artery endothelial cells (HCAECs)
exposed to high glucose condition. The present study explored the role of S1P/S1PR2
in diabetic vascular endothelial dysfunction and underlying mechanism, which may
provide S1P/S1PR2 pathway as therapeutic target to prevent and treat vascular
endothelial dysfunction in diabetes mellitus.
Methods: NO level, endothelial nitric oxide synthase (eNOS), intercellular adhesion
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) protein
expression were measured in HCAECs by commercial kit and western blot, respec-
tively. MiRNA-31 level was detected by real-time PCR. After treatment by different
methods including S1PR2 speciﬁc antagonist, small molecular RNA interference,
overexpression of S1PR2, tranfection of miRNA mimic and inhibitor respectively, the
above indexes of endothelia cells function were investigated in HCAECs cultured
under 25mM high glucose condition. The target gene of miRNA-31 was predicted
using microRNA on-line analysis software and validated by dual-luciferase reporter
gene system and western blot.
Results: NO level and eNOS protein level were decreased, ICAM-1 and VCAM-1
protein level were increased signiﬁcantly in HCAECs by S1P treatment or S1PR2
overexpression. The enhanced NO level and eNOS protein as well as the decreasedJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BICAM-1 and VCAM-1 protein expression were observed after treatment with
sphingosine kinase-1 inhibitor DMS, S1PR2 speciﬁc antagonist JTE-013 and speciﬁc
S1PR2-siRNA respectively in HCAECs induced by S1P under high glucose condi-
tion. MiRNA-31 expression in indicated cells induced by S1P was also inhibited by
JTE-013 and S1PR2-siRNA. Moreover, the HCAECs co-transfected S1PR2-siRNA
and miRNA-31 mimic were shown the decreased in NO level and eNOS protein level
while the increased in adhesion molecule protein expression including ICAM-1 and
VCAM-1. The reversal effects were found in HCAECs overexpressed S1PR2 and
transfected miRNA-31 inhibitor together. Additionally, microRNA on-line analysis
software was used to predict the target of miRNA-31 and found that there was possible
binding sequence of miRNA-31 in human eNOS mRNA 3’-UTR. Furthermore, the
result of dual luciferase reporter gene experiment shown that the luciferase activities
were inhibited by overexpressed miRNA-31 at the presence of the wild type human
eNOS mRNA 3’-UTR, which can be abrogated by mutations in seed complementary
site. Protein expression of eNOS in miRNA-31 transduced cells was examined to be
suppressed after miRNA-31 transfection. Together, our results demonstrated that
eNOS was direct target of miRNA-31.
Conclusions: S1P/S1PR2 mediated vascular endothelial cells dysfunction by upre-
gulating miRNA-31 expression in HCAECs exposed to high glucose.
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A genetic association study for polymorphisms of platelet membrane
glycoprotein and coronary artery disease
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Objectives: To study the association of platelet membrane glycoprotein poly-
morphism (GP I aC807T, GP I baKOZAK-5T/C, GP VI T13254/C, HPA-1 and HPA-
2) and coronary heart disease (CHD).
Methods: A case-control study design was adopted. The study group consisted of
150 patients (mean age¼63.9110.45 year) with coronary artery disease identiﬁed
by coronary angiography and 153 individuals (mean age¼64.6510.80 year)
without coronary artery disease. A newly-developed technology named improved
Multiplex Ligation Detection Reaction, iMLDR, was used to detect target genes and
SNPs. The risk factors for coronary artery disease were analyzed by logistic
regression.
Results: (1) For GP I aC807T, the comparisons of genotype and allele distributions
between cases and controls were signiﬁcant statistically (X2¼6.640, P¼0.036 and
X2¼5.725,P¼0.017, respectively). But for GP I baKOZAK-5T/C, GP VI T13254/C,
HPA-1 and HPA-2, the distributions of genotypes and alleles were not different
signiﬁcantly between cases and controls respectively. (2) Even adjusted by gender,
blood glucose, ﬁbrinogen and triglyceride, still the results from logistic analysis
showed that more than 4 times risks for coronary artery disease were increased by TT
genotype than CC genotype of GP I aC807T. (3) An association between mutant allele
numbers of platelete membrane glycoprotein included in this study and coronary
lesion was found by logistic regression analysis (OR¼1.36,P¼0.008,95%CI¼1.082-
1.707).
Conclusions: Even though traditional risk factors were still important causes of
coronary artery disease, the genetic risk factors should not be neglected. The poly-
morphism of GP I aC807T correlates signiﬁcantly with coronary artery disease, and
TT genotype is independent risk factor for coronary artery disease.
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PPARg agonist Pioglitazone Suppresses AngII-induced Inﬂammation in Cardiac
Fibroblast Cells via TLR4-depended Signaling Pathway
Gao Dengfeng, Zhe Meng, Zhongwei Liu, Xin Dong, Gao Dengfeng
Department of Cardiology, The Second Afﬁliated Hospital, Xi’an Jiaotong University
School of Medicine
Objectives: AngiotensinII (AngII) as an important pro-inﬂammatory factor pro-
motes the pathogenesis of hypertension remarkably, regardless in arteries or hearts.
The activation of Toll-like receptor 4 (TLR4) is one of key pathogenic factors of
the development of hypertension via expressing different kinds of cytokines.
Peroxisome proliferator-activated receptorg (PPARg) has been proved to play a
crucial role in the negative regulation of inﬂammation in many organs and the
growing evidences exhibit that the beneﬁts of PPARg agonists in hypertension
may been via its anti-inﬂammatory and antiﬁbrotic effects. The present study
evaluated the regulation of AngII-induced inﬂammatory responses by pioglitazone
both in vivo and vitro.
Methods: Hypertension spontaneous rats (SHRs) and Wistar Kyto rats (WKYs) were
treated with pioglitazone or saline for 8 weeks. Left ventricular tissues were harvest
for further analysis. Real-time RT-PCR, immunohistochemistry, western blot and
ELISA assay were performed in cultured cardiac ﬁbroblast cells or heart tissue. MTT
assay and ﬂow cytometry were used to measure cell proliferation.
Results: The rise of systolic blood pressure in SHRs was attenuated by pioglitazone.
In SHRs, the generation of monocyte chemotactic protein-1 (MCP-1), tumor necrosis
factor-a (TNF-a), TLR4, myeloid differentiation primary response gene 88 (Myd88)
and Nuclear factor kB (NF-kB) were remarkably increased; however, cotreatment
with pioglitazone diminished these changes and increased the nuclear-PPARg
expression. Treatment of CFs with TLR4 small-interfering RNA (siRNA) show thatasic and Translational Medicine C13
AngII-induced inﬂammation were partly related to TLR4. Cotreatment of CFs with
pioglitazone and AngII revealed no effect on AngII TypeI receptor (AT1), but
downregulated AT1-dependent ERK1/2 phosphorylation. Furthermore, pioglitazone
inhibited AngII-induced MCP-1 and TNF-a production and overexpression of TLR4,
Myd88 and NF-kB; and increased nuclear-PPARg production in CFs.
Conclusions: These results suggest that TLR4 is involved in the AngII-induced in-
ﬂammatory responses in CFs, and pioglitzone provides its anti-inﬂammatory and
antiﬁbrotic effect which is partly depend on interfering with the TLR4-dependent
signaling pathway (AT1/ERK1/2/TLR4/Myd88/NF-kB) to prevent the hypertension
induced ventricle remodeling.
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Ambulatory Blood Pressure Monitoring of Healthy Chinese Children Aged
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Objectives: We studied the characteristics of ambulatory blood pressure (ABP) and
their inﬂuence factors in healthy Chinese children.
Methods: Casual blood pressure (BP), ABP, body height, weight, body mass index
(BMI), personal and familial medical histories were recorded in 338 Chinese children
(aged 5-12 years). Data were treated by ABP database system and analyzed by SPSS
20.0 including correlations, regressions and conventional statistical methods.
Results: Means of 24-Hour SBP/DBP/PP (systolic BP/diastolic BP/pulse pressure)
were 112.710.2/66.35.7/46.67.3 and 110.98.1/66.55.1/44.66.0 mmHg in
normal weight 118 boys and 139 girls, and were 118.311.3/67.96.5/50.78.7 and
113.621.4/65.712.2/48.111.5 mmHg in overweight 46 boys and 35 girls,
respectively. BMI, weight and gender were primary inﬂuencing factors on ABP-
derived parameters. Overweight children had higher means (P<.01 or <.05) of sys-
tolic BP (SBP) and pulse pressure (PP), and higher hypertensive prevalence (35% vs.
15% for boys and 40% vs. 18% for girls) than normal weight children. Boys had
higher (P <.01) means of PP (24-Hour /Daytime) than girls in normal weight children.
Age related negatively with DBP and body height correlated with heart rate. Circadian
variations of ABP (dipper pattern) were seen in most of children (76%). Familial
histories of hypertension showed no inﬂuence on ABP.
Conclusions: BMI, weight and gender were the main inﬂuencing factors on ABP
in Chinese children and our data provides basic information of ABP in Chinese
children.
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Treatment of Myocardial Infarction by Transplantation of Adiponectin
Gene-Modiﬁed Stromal Vascular Fraction cells from Adipose Tissue
Zheng Suli, Liangdi Xie
Fujian Hypertension Research Institute, First Afﬁliated Hospital of Fujian Medical
University
Objectives: The aim of this study was to investigate the effect of the human adipo-
nectin (Hapm1) gene-modiﬁed stromal vascular fraction (SVF) cells (Hapm1-SVF)
transplantation on the cardiac function and histological changes of heart tissue in rats
with myocardial infarction.
Methods: Rats were divided into four groups (n¼8) : sham-operated (sham), un-
treated myocardial infarction (MI), SVF treated (SVF), and HapM1-SVF (SVF car-
rying human adiponectin gene and labeled with EGFP) treated (HapM1-SVF) groups.
The MI model was established by ligation of the left anterior descending coronary
arteries. SVF were injected into the infracted border zone of MI rats. EF and FS were
detected by echocardiography 4 weeks after the cells transplantation. LVSP and
LVDP were measured by PowerLab biological signal analytical system. Vascular
density was determined by immunohistochemical staining.
Results: It was shown that LVSP and LVDP were signiﬁcantly increased in MI rats
treated with SVF cells or HapM1 gene-modiﬁed SVF cells as compared with untreated
MI rats, but still not reach the normal level [LVSP: sham (99.357.45) VS MI
(72.835.37) VS SVF (77.857.82) VS Hapm1-SVF (84.238.65) mmHg, P<0.05].
EF and FS of rats in HapM1-SVF or SVF groups were signiﬁcantly higher than that of
MI rats, but still not reach the normal level (EF: sham (81.854.63%) VS MI
(43.213.10%) VS SVF (64.934.13%) VS Hapm1-SVF (74.563.60%), P<0.05).
Meanwhile, the density of vessels in HapM1-SVF group was higher than that in SVF
or MI group, but still lower than that in sham group.
Conclusions: In summary, transplantation of SVF cells carrying hapM1 gene may
stimulate recovery of cardiac function after myocardial infarction in rats.
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Klotho Deﬁciency Causes Hypertension and Renal Damage and Its Mechanism
Zhou Xiaoli1, Lei Han1, Sun Zhongjie2
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Oklahoma Health Sciences Center
Objectives: Klotho (KL) is a recently discovered aging-suppressing gene. Insertional
mutation of KL gene resulted in a premature aging syndrome. Overexpression of KLC14 JACC Vol 64/16/Suppl C j Octobgene extended the lifespan by 20% and rescued other aging disorders. Hypertension
and kidney damage are common aging-related diseases. The purpose of this study is to
assess if KL deﬁciency affects blood pressure (BP) and renal damage as well as the
underlying mechanism.
Methods: One group of heterozygous mutant KL (KL (+/-) ) mice and one group of
wild type (WT) mice were used to measure BP continuously when they were from the
age of 8 months to 13 months. Each strain of mice was further divided into 2 sub-
groups when the mice were at the age of 15 months, which received eplerenone
treatment (6 mg/kg/day, IP) or an equal dose vehicle, respectively. BP was measured
and urine was collected during treatment. At the end of the treatment for 3 weeks, the
animals were sacriﬁced and blood was collected. Plasma aldosterone level was
detected with an aldosterone ELISA kit. Kidney sections were used for periodic acid
Schiff staining, Masson’s trichrome staining and immunohistochemical staining (CD4,
CD8, and CD68). Adrenal sections were used for immunohistochemical staining
(klotho, CYP11B2). Plasma urea and creatinine level were detected with quanti-
chromTM assay kits. Urinary albumin concentration was measured with a micro-
albuminuria ELISA kit. Western blotting was done to detect the expression of MR,
SGK1, NCC, and ATP synthase b, TNF-a, MCP-1, IL-6 and osteopontin in kidney.
Results: The results demonstrated that the systolic BP was signiﬁcantly and persis-
tently elevated accompanied by aldosterone level increase and CYP11B2 (key enzyme
of aldosterone synthesis) upregulation in KL (+/-) mice. Chronic treatment with
eplerenone (aldosterone receptor blocker) decreased hypertension to the control level
and prevented the upregulation of SGK1, NCC and ATP synthase b level in kidneys
of KL (+/-) mice, suggesting that KL deﬁciency causes hypertension due to plasma
aldosterone increase and the subsequent renal sodium retention through SGK1-NCC
signaling. Moreover, signiﬁcant renal structure damage (glomerulus collapse, tubule
ﬁbrosis) and function decline (plasma creatinine, urea and urine albumin increase)
were observed in KL (+/-) mice. Further analysis indicated that several proin-
ﬂammatory cytokines (TNFa, MCP-1, IL-6 and osteopontin) were upregulated and
leucocyte (T cell and macrophage) inﬁltration were increased in kidneys of KL (+/-)
mice. Eplerenone rescued KL deﬁciency-induced kidney damage and abolished the
activated inﬂammatory process.
Conclusions: KL is essential to the maintenance of normal BP. KL deﬁciency caused
hypertension and kidney damage via upregulating aldosterone level and consequently
increasing inﬂammation and SGK1-NCC signaling in kidneys.
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Cellular repressor of E1A-stimulated genes protects against angiotensin
II-induced hypertension and vascular remodeling via p38MAPK-mediated
regulation of the renin-angiotensin system
Li Yang, Han Yaling
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Objectives: Cellular repressor of E1A-stimulated genes (CREG) has been proposed to be
a new cardiovascular homeostasis regulator. We hypothesized that CREG is a negative
regulator of angiotensin (Ang) II-mediated hypertension and vascular remodeling.
Methods: Ten-week-old male heterozygous CREG-deﬁcient (CREG+/-) mice and
their littermate wild-type (WT) mice were implanted with osmotic minipumps con-
taining saline, Ang II (1.5 mg/kg$d), or Ang II and recombinant human CREG
(rhCREG; 15-300 mg/kg$d) protein for 14 days. Ang II-infused CREG+/- mice were
then cotreated with p38 MAPK inhibitor, SB203580 (10 mg/kg$d), beginning 2 days
before minipump implantation. Systolic blood pressure (SBP); extent of vascular
remodeling; RNA and protein level of CREG, collagen type I/III, angiotensin-con-
verting enzyme-2 (ACE2), angiotensin receptor type 1 (AT1R), Ets-1 and MAPK
were evaluated. Primary vascular smooth muscle cell (VSMC) culture was performed
to assess the mechanism of Ang II-induced CREG down-regulation, as well as CREG-
mediated modulation of renin-angiotensin system.
Results: CREG levels are high in vascular media under basal conditions but rapidly
decrease in response to Ang II. Ets-1 transcription factor expression is upregulated in
Ang II-stimulated VSMCs. Chromatin immunoprecipitation analysis showed the
interaction of endogenous and exogenous Ets-1 or glutathione S-transferase-tagged
Ets-1, bearing only the DNA-binding domain with the authentic CREG promoter.
Moreover, Ets-1 siRNA knockdown signiﬁcantly reduced Ang II-induced repression
of CREG expression, indicating Ets-1 mediates Ang II-induced down-regulation of
CREG expression. Ang II infusion for 14 days resulted that levels of SBP, intima
medial thickness and vascular remodeling of the aorta and mesenteric artery were
signiﬁcantly greater in CREG+/- mice compared with the WT controls. Vascular gene
expression level of CREG was lower in Ang II-treated CREG+/- mice than in WT
mice, suggesting that CREG deﬁciency aggravates Ang II-induced hypertension and
vascular remodeling. However, daily treatment of Ang II-infused WT mice with
rhCREG protein improved the above phenotypes. Ang II-induced vascular remodeling
was inhibited by rhCREG protein in association with reduced plasma Ang II and
increased plasma Ang 1-7 levels. Furthermore, rhCREG treatment inhibited Ang II-
mediated up-regulation of AT1R expression and down-regulation of ACE2 expression
by blocking p38MAPK activation. Finally, pharmacological blockade of p38MAPK
with SB203580 abolished CREG deﬁciency mediated the aggravation of Ang II-
induced hypertension and vascular remodeling.
Conclusions: Ets-1 mediates Ang II-induced down-regulation of CREG expression.
Elevated Ang II induced hypertension and vascular remodeling, which were exac-
erbated by CREG deﬁciency, whereas rhCREG protein attenuated Ang II-induced
hypertension and vascular remodeling through modulation of balance betweener 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
